Regeneca Given Distribution Rights for CardioMap
"We are very excited about this deal, as the distribution with Regeneca Worldwide offers an incredible opportunity for the advancement of this technology in terms of awareness and applicability in the daily lives of individuals," stated Vladimir Podlipskiy, the Chief Science Officer of VE Science Technologies LLC. "CardioMap provides the basis for an analysis of a person's heart health condition. This analysis is achieved through an examination that measures heart performance and visualizes the results in dynamic, colorful heart portraits generated through an online service. This invaluable service addresses unmet needs in early screening and monitoring for heart disease, and other health related conditions."
"CardioMap provides a way for our distributors to instantly demonstrate the effectiveness of the Regeneca product line, with individualized data for our consumers," said Trent Staggs, President of Regeneca Worldwide, Inc.
CardioMap depicts disease or stress levels as a 3D image supplementing the line drawing electrocardiogram. The system evaluates the stability of current heart conditions. It is highly portable and provides a rapid analysis in 30 or 60 seconds. The device is connected through the Internet to the central server that converts the electric conductivity of the cardiac tissue into a three-dimensional, color-coded and easy-to-interpret visual portrait. This heart portrait allows customers and physicians to observe the condition of the heart muscle and the intensity of the heart stress load quickly and easily.
Related News
-
Regeneca Shutting Down
Regeneca Worldwide has been ordered to cease operations by the Department of Justice, which filed a consent decree of permanent injunction against the company and its CEO, Matthew Nicosia, alleging that they violated the Federal Food, Drug and Cosmetic Act (FDCA) by manufacturing and distributing Re... Read More...Regeneca Given Distribution Rights for CardioMap
Cottonwood Heights, UT June 11, 2015 -- Regeneca Worldwide has entered into an exclusive distribution agreement with VE Science Technologies LLC, the creators of the CardioMap heart screening and monitor device, for the network marketing industry."We are very excited about this deal, as the ... Read More...
Regeneca Worldwide Announces New President
Cottonwood Heights, UT May 14, 2015 -- Regeneca Worldwide has concluded their search for a new President and are pleased to announce that Mr. Trent Staggs will now lead the company in this role."We are thrilled to have Trent Staggs join the Regeneca team and lead the company's operations," s... Read More...
Regeneca Worldwide Recalls RegenESlim Capsules
Inc. Las Vegas, NV is conducting a voluntary nationwide recall of its RegenESlim appetite control dietary supplement from lot # EX0616R15814 and lot #11414RE5516 because FDA analysis confirmed the presence of DMAA. DMAA is also known as 1,3-dimethylamylamine, methylhexanamine, or geranium extract. ... Read More...
